Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis
Open Access
- 1 December 2016
- journal article
- review article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (9) , 16017-16026
Abstract
Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysisKeywords
This publication has 43 references indexed in Scilit:
- Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic ReviewPLOS ONE, 2013
- AMPK Activators Suppress Cervical Cancer Cell Growth through Inhibition of DVL3 Mediated Wnt/β-Catenin Signaling ActivityPLOS ONE, 2013
- The Influence of Type 2 Diabetes and Glucose-Lowering Therapies on Cancer Risk in the TaiwaneseExperimental Diabetes Research, 2012
- The influence of metformin in the etiology of selected cancersContemporary Oncology, 2012
- Cellular and molecular mechanisms of metformin: an overviewClinical Science, 2011
- Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individualsBMC Cancer, 2011
- Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical trialsDiabetologia, 2010
- New Users of Metformin Are at Low Risk of Incident CancerDiabetes Care, 2009
- Thiazolidinedione Therapy Is Not Associated With Increased Colonic Neoplasia Risk in Patients With Diabetes MellitusGastroenterology, 2008
- Measuring inconsistency in meta-analysesBMJ, 2003